Navigation Links
Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War
Date:6/25/2009

SAVANNAH, Ga., June 25 /PRNewswire/ -- Jellyfish Squish(TM), an FDA compliant solution that works within minutes to relieve the pain of jellyfish stings, was recently proved to be effective on stings caused by the Portuguese man-of-war. Jellyfish Squish(TM) is produced by Coastal Solutions, Inc. in Savannah, Ga., and can be purchased online and at select stores including drug stores and beach supply stores.

In May of 2009 Dr. Peter Verity, a world renowned marine biologist at the Skidaway Institute of Oceanography (an internationally-recognized, multidisciplinary research institution within the University of Georgia system charged with conducting leading edge research on marine resources) was petitioned to conduct a series of scientific experiments to determine whether Jellyfish Squish(TM)'s active ingredient lidocaine, would also relieve the sting of Portuguese man-of-war. Often mistaken for jellyfish, a Portuguese man-of-war is an invertebrate whose tentacles can reach up to 30 feet in length. It lives around the surface of warm ocean waters throughout the world, and can cause painful stings if its tentacles come into contact with human flesh and release its nematocysts.

Several experiments were conducted to determine which products would stop the discharging of nematocysts released from Portuguese man-of-war. Nematocysts are hollow pointed or corkscrew-shaped barbs, which are released when tentacles come into contact with human flesh, causing a painful stinging sensation. After much testing under a microscope, the scientific data proved that applying Jellyfish Squish(TM) on a Portuguese man-of-war paralyzes the unfired nematocysts, preventing them from continuing to fire their toxins. Vinegar, ammonia and other products tested did not paralyze the nematocysts and actually caused the remaining

nematocysts to fire.

Jellyfish Squish founder J.C. Grayson created the product so that beach-goers could enjoy the ocean without the worry of jellyfish stings. Rather than causing more intense pain by using home remedies such as ammonia, vinegar, meat tenderizer and urine, he wanted sting victims to be able to use a scientifically tested medical treatment that would effectively relieve the pain. Jellyfish Squish(TM) contains the maximum amount of lidocaine that is allowed without a prescription. Lidocaine penetrates the skin within 30 seconds to stop the nerve receptors from sending pain signals. It also stops the remaining sting cells left on the skin from discharging their toxins. Lidocaine is used in doctors' offices, hospitals and burn units.

According to Dr. Paul Auerbach, Professor of Surgery at Stanford University School of Medicine, Jellyfish Squish(TM) is the best choice for the treatment of jellyfish stings and other pain relief. "It makes perfect sense to me that topical lidocaine hydrochloride should be effective for jellyfish stings, as it is a non-specific anesthetic agent that is capable of numbing superficial skin no matter what the irritant," Dr. Auerbach said. "I intend to carry a spray vial and to utilize it the next time I am bitten or stung, which is inevitable."

Since it came on the market in 2008, Jellyfish Squish(TM) has quickly gained numerous satisfied customers. The product is endorsed by the American Lifeguard Association, and was recently featured on an episode of The Doctors, a nationally syndicated talk show airing daily in the United States and Canada. B. J. Fisher, Director of Health and Safety for the American Lifeguard Association, was interviewed on The Doctors to discuss beach safety, and named Jellyfish Squish(TM) as an essential item to have on the beach.

"Jellyfish Squish(TM) is a product the American Lifeguard Association is proud to give our stamp of approval," said Fisher. "Its main ingredient, lidocaine, is truly effective in its treatment of jellyfish stings. I believe that Jellyfish Squish(TM) is one of the things no one should be without on the beach."

Along with founder, J.C. "Chip" Grayson, Jellyfish Squish(TM) was developed with the help of two marine scientists from the Skidaway Institute of Oceanography. Hundreds of clinical sting tests were performed on jellyfish sting victims on South Carolina, Georgia and Florida beaches to determine which sting solutions relieved the pain fastest and with the most efficiency. Within two minutes of spraying Jellyfish Squish(TM), 100 percent of those tested reported much or complete relief.

Jellyfish Squish(TM) is produced by Coastal Solutions, Inc. in Savannah, Ga. In addition to Jellyfish Squish(TM), Coastal Solutions manufactures additional products for bug bites and other irritants including Bite Fixer, Bite Blaster, Fire Ant Coolant and Chigger Chaser. For more information about Jellyfish Squish(TM) or Coastal Solutions, Inc. call (912) 353-3368, email info@coastalsolutionsinc.com, or go to www.jellyfishsquish.com.


'/>"/>
SOURCE Coastal Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs
2. Intralase “Bladeless” Lasik Gains Popularity in the Raleigh, NC Area
3. Popular Alzheimers theory may be false trail
4. Safety and Quality Contribute to Popularity of Assisted Living
5. As Biking Popularity Grows, so Must the Spotlight on Safety
6. Carnival Corporation & plc Reports Financial Impact of Itinerary Changes Responding to H1N1 Influenza Mexico Travel Advisory; Plans Rapid Return to Popular Mexican Ports
7. Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter
8. Medical Tai Chi (Qigong) - Chinese Miracle Exercise Popular as U.S. Health Costs Rise
9. Popular diabetes treatment could trigger pancreatitis, pancreatic cancer
10. Renowned Smoking Cessation Expert Launches Popular Stop Smoking Seminar in UK
11. Breast Augmentation: Survey Highlights Recent Trends In Today's Most Popular Cosmetic Surgery Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... St. Louis, Missouri (PRWEB) , ... February 10, ... ... 11-14, 2016, in San Diego, will bring together more than 200 of the ... in healthcare for the future. , “The true benefit of the Forum is ...
(Date:2/10/2016)... ... 10, 2016 , ... AHRA: The Association for Medical Imaging ... Fox will serve as keynote speaker at the organization’s 2016 Spring Conference. Fox’s ... more effectively communicate with their own organizational staff and leadership. , “I ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent article published ... number of patients under the age of 30. According to Southern California based medical ... and may indicate an overall shift in the rapidly growing social acceptance of cosmetic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... new market research report "Pharmaceutical Packaging Equipment Market by ... Labeling & Serialization), by Product Type (Tablet, Powder, Cream, ... published by MarketsandMarkets, studies the global market during the forecast ... to grow at a CAGR of 6.9% during the ...
(Date:2/10/2016)... On Tuesday, February 9th, the U.S. ... its Arthritis Advisory Committee to discuss Celltrion,s ... Johnson,s Remicade and most likely the second ... The Biologics Prescribers Collaborative (BPC) along with ... Patient Access, American Association of Clinical Endocrinologists, ...
(Date:2/10/2016)... 10, 2016 --> ... Therapeutics and Companion Diagnostic Market to 2019 - ... Environment" research report indicates that the core personalized ... by 2020 growing at a CAGR of 8.74%. ... and targeted therapeutics and is dominated by oncology, ...
Breaking Medicine Technology: